Live Breaking News & Updates on கிளார்க் தீர்வுகள்

Stay updated with breaking news from கிளார்க் தீர்வுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Verista Acquires Hawkins Point to Supercharge Business and Technology Prowess Across the Drug Development Lifecycle


Verista Acquires Hawkins Point to Supercharge Business and Technology Prowess Across the Drug Development Lifecycle
News provided by
Share this article
Share this article
INDIANAPOLIS, Feb. 2, 2021 /PRNewswire/  Verista, a leading transformative compliance and automation solutions organization for the life sciences industry, recently acquired Hawkins Point, a leader in life sciences business and technology services. The acquisition expands and improves Verista s scope of services and capabilities, adding research and development (R&D) and commercialization technology capabilities for large pharma, early-stage biotech and medical device companies, while broadening its geographic footprint to better support its clients growing needs.
The addition of Hawkins Point, based in Massachusetts, leverages Verista s pedigree in FDA-regulated services in information technology and manufacturing technology. It completes Verista s lifecycle support for life sciences comp ....

United States , Heather Morris Kyer , Clarke Solutions , Led Companies , Goodwin Procter , Carl Marks Securities , Adding Hawkins Point , Hawkins Point , Manny Soman , New England , Lightview Capital , Maranon Capital , Boston Business Journal , Women President Organization , ஒன்றுபட்டது மாநிலங்களில் , ஹீத்தர் மோரிஸ் கியேற் , கிளார்க் தீர்வுகள் , வழிநடத்தியது நிறுவனங்கள் , குட்வின் ப்ராக்‌டர் , கார்ல் மதிப்பெண்கள் பத்திரங்கள் , ஹாக்கின்ஸ் பாயஂட் , மேனி சோமன் , புதியது இங்கிலாந்து , போஸ்டன் வணிக இதழ் , பெண்கள் ப்ரெஸிடெஂட் ஆர்கநைஸேஶந் ,

Verista acquires Hawkins Point for Business and Technology Prowess throughout the drug development life cycle


Verista acquires Hawkins Point for Business and Technology Prowess throughout the drug development life cycle
News Highlights: Verista acquires Hawkins Point for Business and Technology Prowess throughout the drug development life cycle
“Hawkins Point’s expertise in R&D and commercialization is a natural extension of Verista’s capabilities.”
tweet this
Recommended
“The Hawkins Point team shares Verista’s mission to trust and ultimately improve patients’ quality of life,” said Heather Morris Kyer, Hawkins Point co-founder, who will join Verista’s leadership team. “We are thrilled to be an important part of Verista as we collectively gain greater scale and capabilities to serve our customers.” ....

United States , Heather Morris Kyer , Clarke Solutions , Technology Prowess , Goodwin Procter , Carl Marks Securities , List Of Fastest Growing Private Companies , News Highlights , Hawkins Point , Manny Soman , New England , Lightview Capital , Maranon Capital , Hawkins Point Based , Fastest Growing Private , Boston Business Journal , Women President Organization , ஒன்றுபட்டது மாநிலங்களில் , ஹீத்தர் மோரிஸ் கியேற் , கிளார்க் தீர்வுகள் , தொழில்நுட்பம் வலிமை , குட்வின் ப்ராக்‌டர் , கார்ல் மதிப்பெண்கள் பத்திரங்கள் , பட்டியல் ஆஃப் வேகமாக வளர்ந்து வரும் ப்ரைவேட் நிறுவனங்கள் , செய்தி சிறப்பம்சங்கள் , ஹாக்கின்ஸ் பாயஂட் ,

Gosse caps decade of research into troublesome triclosan - UMaine News


Gosse caps decade of research into troublesome triclosan
University of Maine toxicologist Julie Gosse spent a decade unearthing the medical harm posed by the germ-fighting agent triclosan (TCS).
Manufacturers had included the synthetic chemical in soap, toothpaste, facial cleansers, sanitizer and other common products since the 1970s, when no research delved into its health and toxicological effects. Products containing the antimicrobial agent filled store shelves. By the time Gosse and her students began investigating it, 75% of Americans were exposed to it, according to the National Health and Nutrition Examination Survey.
Various studies in the past 10 years, however, have revealed problems with TCS, that it weakens disease resistance and interferes with various bodily functions. Research led and overseen by Gosse, an associate professor of biochemistry, found TCS inhibits immune cells, particularly T and mast cells, and damages mitochondria. Investigations from oth ....

United States , University Of Maine At Augusta , Harvard University , West Virginia , University Of Maine At Farmington , University Of Maine , University Of Maine At Presque Isle , Alan Baez Vasquez , Sam Hess , Rachel Kennedy , Julie Gosse , Susan Richardson , Suraj Sangroula , Baez Vasquez , Baez Vazquez , Marcus Wolf , Elisa Weatherly , Sasha Weller , Clarke Solutions , National Health , Serono Inc , School Of Biomedical Sciences , Society Of Toxicology Undergraduate Student Research Award , Nutrition Examination , Centers For Disease , Prevention National Institute For Occupational Safety ,